The association of body mass index with overall survival, progression free survival and locoregional control in head and neck cancer treated with curative-intent definitive chemoradiation

被引：0
作者：
Chatterjee, Udit
Ma, Sung Jun
Khan, Michael
Santhosh, Sharon
Hashmi, Mahnoor
Gill, Jasmin
Yu, Brian
Iovoli, Austin
Farrugia, Mark
Yu, Han
Singh, Anurag K.
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[2] Jacobs Sch Med & Biomed Sci, Buffalo, NY USA
[3] Dow Int Med Coll, Karachi, Pakistan
[4] SUNY Buffalo, Buffalo, NY USA
[5] SUNY Buffalo, Sch Med, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18062
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Bayesian Sensitivity Analysis to Partition Body Mass Index Into Components of Body Composition: An Application to Head and Neck Cancer Survival
    Bradshaw, Patrick T.
    Zevallos, Jose P.
    Wisniewski, Kathy
    Olshan, Andrew F.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2019, 188 (11) : 2031 - 2039
  • [32] Tumor Volume Predicts Tumor Control and Survival among Patients with Locally Advanced Head and Neck Cancer undergoing Definitive Chemoradiation Therapy
    Strongin, A.
    Yovino, S.
    Taylor, R.
    Wolf, J.
    Cullen, K.
    Ord, R.
    Zimrin, A.
    Strome, S.
    Regine, W.
    Suntharalingam, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S405 - S406
  • [33] Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
    De Giorgi, Ugo
    Procopio, Giuseppe
    Giannarelli, Diana
    Sabbatini, Roberto
    Bearz, Alessandra
    Buti, Sebastiano
    Basso, Umberto
    Mitterer, Manfred
    Ortega, Cinzia
    Bidoli, Paolo
    Ferrau, Francesco
    Crino, Lucio
    Frassoldati, Antonio
    Marchetti, Paolo
    Mini, Enrico
    Scoppola, Alessandro
    Verusio, Claudio
    Fornarini, Giuseppe
    Carteni, Giacomo
    Caserta, Claudia
    Sternberg, Cora N.
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3839 - 3846
  • [34] G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
    Pottel, Lies
    Lycke, Michelle
    Boterberg, Tom
    Pottel, Hans
    Goethals, Laurence
    Duprez, Frederic
    Rottey, Sylvie
    Lievens, Yolande
    Van Den Noortgate, Nele
    Geldhof, Kurt
    Buyse, Veronique
    Kargar-Samani, Khalil
    Ghekiere, Veronique
    Debruyne, Philip R.
    BMC CANCER, 2015, 15
  • [35] G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
    Lies Pottel
    Michelle Lycke
    Tom Boterberg
    Hans Pottel
    Laurence Goethals
    Fréderic Duprez
    Sylvie Rottey
    Yolande Lievens
    Nele Van Den Noortgate
    Kurt Geldhof
    Véronique Buyse
    Khalil Kargar-Samani
    Véronique Ghekiere
    Philip R. Debruyne
    BMC Cancer, 15
  • [36] Association of body mass index (BMI) with progression-free survival (PFS) in patients with advanced renal cell cancer (RCC) treated with targeted therapies.
    Dhaliwal, J.
    Gill, H. S.
    Chung, B. I.
    Harshman, L. C.
    Rajan, K.
    Srinivas, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patients
    John, Katharina
    Roesner, Imme
    Keilholz, Ulrich
    Gauler, Thomas
    Bantel, Heike
    Gruenwald, Viktor
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (12) : 1596 - 1602
  • [38] Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer
    Maria Hentschel
    Steffen Appold
    Andreas Schreiber
    Nasreddin Abolmaali
    Andrij Abramyuk
    Wolfgang Dörr
    Joerg Kotzerke
    Michael Baumann
    Klaus Zöphel
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1203 - 1211
  • [39] Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer
    Hentschel, Maria
    Appold, Steffen
    Schreiber, Andreas
    Abolmaali, Nasreddin
    Abramyuk, Andrij
    Doerr, Wolfgang
    Kotzerke, Joerg
    Baumann, Michael
    Zoephel, Klaus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (07) : 1203 - 1211
  • [40] Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial
    Barrett, S. V.
    Paul, J.
    Hay, A.
    Vasey, P. A.
    Kaye, S. B.
    Glasspool, R. M.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 898 - 902
12345